ICMR initiates process of vaccine against avian influenza

The ICMR has launched efforts to develop a human vaccine against the highly-pathogenic avian influenza H5N1. This virus poses a significant public health risk due to its high mortality rate and potential to cause global pandemic. Recent outbreaks highlight the urgency of vaccine development for better preparedness.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/8vREa9O
via IFTTT